Infliximab in steroid-resistant ulcerative colitis: A randomised controlled trial

被引：0
|
作者：
Probert, CSJ
Hearing, SD
Schreiber, S
Kuhbacher, T
Ghosh, S
Forbes, A
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
772
引用
收藏
页码：A99 / A99
页数：1
相关论文
共 50 条
  • [41] Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial
    Pierluigi, Carratu
    Silvano, Dragonieri
    Onofrio, Resta
    SWISS MEDICAL WEEKLY, 2019, 149
  • [42] Japanese pediatric patient with refractory steroid-resistant ulcerative colitis successfully treated with Tofacitinib A case report
    Kakiuchi, Toshihiko
    Yoshiura, Masato
    MEDICINE, 2022, 101 (45) : E31757
  • [43] Infliximab and Methycillin Resistant Staphylococcus aureus in Ulcerative Colitis
    Williamson, Alice
    Morris, Brian
    Serrano, Maria-Stella
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S402 - S402
  • [44] Basiliximab for the treatment of steroid resistant ulcerative colitis
    Creed, TJ
    Dayan, CM
    Probert, CSJ
    Hearing, SD
    GUT, 2004, 53 : A97 - A97
  • [45] Steroid-refractory ulcerative colitis-ciclosporin or infliximab?
    Kaur, Manreet
    Targan, Stephen R.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (01) : 8 - 9
  • [46] A 2-year follow-up of the swedish-danish Infliximab/Placebo trial in steroid resistant acute ulcerative colitis
    Gustavsson, Anders
    Jaenerot, Gunnar
    Hertervig, Erik
    Friis-Iiby, Ingalill
    Blomquist, Lars
    Karlen, Per
    Graennoe, Christer
    Vilien, Mogens
    Stroem, Magnus
    Damelsson, Ake
    Verbaan, Hans
    Hellstroem, Per M.
    Halfvarson, Jonas
    Magnuson, Anders
    Tysk, Curt
    GASTROENTEROLOGY, 2007, 132 (04) : A146 - A147
  • [47] Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
    Vermeire, Severine
    O'Byrne, Sharon
    Keir, Mary
    Williams, Marna
    Lu, Timothy T.
    Mansfield, John C.
    Lamb, Christopher A.
    Feagan, Brian G.
    Panes, Julian
    Salas, Azucena
    Baumgart, Daniel C.
    Schreiber, Stefan
    Dotan, Iris
    Sandborn, William J.
    Tew, Gaik W.
    Luca, Diana
    Tang, Meina T.
    Diehl, Lauri
    Eastham-Anderson, Jeffrey
    De Hertogh, Gert
    Perrier, Clementine
    Egen, Jackson G.
    Kirby, John A.
    van Assche, Gert
    Rutgeerts, Paul
    LANCET, 2014, 384 (9940): : 309 - 318
  • [48] A randomized placebo-controlled trial of infliximab therapy for active ulcerative colitis: ACT 1 trial
    Rutgeerts, P
    Feagan, BG
    Olson, A
    Johanns, J
    Travers, S
    Present, D
    Sands, BE
    Sandborn, W
    Olson, A
    GASTROENTEROLOGY, 2005, 128 (04) : A105 - A105
  • [49] USE OF INFLIXIMAB AS THERAPEUTIC OPTION FOR STEROID-RESISTANT PARADOXICAL REACTION IN TB
    Yoshino, Kenji Y.
    Shrestha, Pallabi
    Upson, Sarah M.
    Klimberg, Nicholas
    CHEST, 2022, 162 (04) : 326A - 326A
  • [50] Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study
    Coates, Elizabeth
    Wickramasekera, Nyantara
    Barr, Amy
    Shackley, Phil
    Lee, Matthew
    Hind, Daniel
    Probert, Christopher
    Sebastian, Shaji
    Totton, Nikki
    Blackwell, Sue
    Bedford, Hugh
    Dames, Nicola
    Lobo, Alan
    HEALTH TECHNOLOGY ASSESSMENT, 2022, 26 (41)
12345